Evidence map›Paper›PMID 27582814›Full record

ArticleObstetric medicine2009

The angiotensin-converting enzyme gene insertion-deletion polymorphism in a white British patient cohort with obstetric cholestasis.

Roman Müllenbach, Natasha Tetlow, Amanda Bennett, Fiona Broughton Pipkin, Linda Morgan, Catherine Williamson

Open access · greenAbstract read
In one paragraph

Article in Obstetric medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Roman MüllenbachKlinik für Innere Medizin II, Universitätsklinikum des Saarlandes , Gebäude 41 Kirrberger Str, 66421 Homburg , Germany.
Natasha TetlowInstitute of Reproductive and Developmental Biology , Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN.
Amanda BennettDiabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ.
Fiona Broughton PipkinDepartment of Obstetrics, City Hospital, Nottingham NG5 1PB.
Linda MorganInstitute of Genetics, University Hospital Nottingham , Nottingham NG7 2UH , UK.
Catherine WilliamsonInstitute of Reproductive and Developmental Biology , Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN.
Imperial College London · GBNottingham City Hospital · GBOxford Centre for Diabetes, Endocrinology and Metabolism · GBUniversitätsklinikum des Saarlandes · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The DD genotype of the angiotensin-converting enzyme (ACE) gene is over-represented in Finnish patients with obstetric cholestasis (OC). The purpose of this study was to establish whether this genotype is associated with cholestasis in UK cases. In a retrospective case-control study, we determined the ACE insertion/deletion frequencies in 166 British cases and 100 control women by polymerase chain reaction analysis. No significant difference in allele frequencies was found between these groups, but allele frequencies differed significantly between Finnish and UK OC cases (P = 0.0005). The prevalence of the DD genotype is lower in UK cases than in controls (χ(2) [1 d.f.] = 4.32, P = 0.05) and the odds ratio for OC associated with the DD genotypeis 0.54, 95% confidence interval 0.30-0.97. In contrast to Finnish OC cases, the DD genotype of the ACE is not increased in UK cases.

Indexed as

angiotensin-converting enzymegene polymorphismobstetric cholestasis

Identifiers

PMID27582814
PMCPMC4989727
OpenAlexW2095307394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.